Hong Kong Media Stock News

SEHK:2007
SEHK:2007Real Estate

Country Garden Holdings SEHK 2007 Valuation Check After 2025 Profit Return And Governance Changes

Country Garden Holdings (SEHK:2007) has reported full year 2025 results with sales of CN¥154,893 million and net income of CN¥3,261 million, alongside board-backed plans to update its Articles of Association. See our latest analysis for Country Garden Holdings. The latest results and governance updates come after a mixed share price pattern, with a 1 day share price return of 1.61% and a 90 day share price return showing a 14.86% decline, while the 5 year total shareholder return indicating a...
SEHK:16
SEHK:16Real Estate

Is It Too Late To Consider Sun Hung Kai Properties (SEHK:16) After 116.8% One-Year Rally?

Wondering if Sun Hung Kai Properties at HK$138.30 is offering genuine value or just reflecting market excitement? This article walks through what the current price might be telling you. The stock has posted returns of 2.7% over the last 7 days, 1.0% over the past month, 43.2% year to date, and 116.8% over the last year, which has put it firmly on many investors' radar. Recent coverage has focused on Sun Hung Kai Properties as one of Hong Kong's large property names, with attention on how it...
SEHK:546
SEHK:546Chemicals

Assessing Fufeng Group (SEHK:546) Valuation After Earnings Growth Dividends And Kazakhstan Expansion Updates

Dividend changes, earnings and Kazakhstan build out put Fufeng Group in focus Fufeng Group (SEHK:546) is back on investors' radar after reporting full year 2025 results, proposing both a special and ordinary dividend, and updating progress on its Kazakhstan production base. For the year ended 31 December 2025, Fufeng Group reported sales of CN¥27,879.19 million and net income of CN¥2,465.23 million. Basic earnings per share from continuing operations were CN¥0.9833, while diluted earnings per...
SEHK:853
SEHK:853Medical Equipment

What MicroPort Scientific (SEHK:853)'s Profit Return and Rotating CEO Overhaul Means For Shareholders

MicroPort Scientific reported full-year 2025 sales of US$994.91 million and net income of US$48.52 million, while announcing that long-time chairman Dr. Zhaohua Chang stepped down as CEO and was replaced by rotating chief executive Jonathan W. Chen alongside the creation of a new Global Executive Committee and a new company secretary. This combination of a turnaround to profitability with a refreshed leadership and governance structure highlights MicroPort Scientific’s push to align...
SEHK:1024
SEHK:1024Interactive Media and Services

Assessing Kuaishou Technology (SEHK:1024) Valuation After Strong 2025 Earnings And Dividend Announcement

Kuaishou Technology (SEHK:1024) shares moved after the company reported quarterly and full year 2025 earnings, together with a recommended final dividend, giving investors fresh data on cash generation, shareholder returns and recent business performance. See our latest analysis for Kuaishou Technology. The latest 4.01% 1 day share price return, to HK$46.7, comes after a tougher few months, with a 30 day share price return of 22.87% decline and a 90 day share price return of 35.05% decline...
SEHK:753
SEHK:753Airlines

Air China Chengdu Brussels Route Tests Long Haul Demand And Profitability

Air China has launched a new direct passenger route between Chengdu and Brussels, creating a fresh air link between China and Belgium. The service is intended to support international connectivity and contribute to the recovery of inbound tourism in Chengdu. The new route forms part of Air China’s wider international network development and aligns with local infrastructure and travel facilitation efforts. For investors tracking Air China (SEHK:753), the new Chengdu to Brussels route lands...
SEHK:2319
SEHK:2319Food

A Look At China Mengniu Dairy (SEHK:2319) Valuation After 2025 Earnings Recovery And Proposed Dividend

China Mengniu Dairy (SEHK:2319) has come into focus after releasing its full year 2025 results and proposing a final ordinary dividend of RMB 0.52 per share, subject to shareholder approval. See our latest analysis for China Mengniu Dairy. The latest earnings and dividend proposal appear to have supported sentiment, with a 30 day share price return of 6.36% and a 90 day share price return of 14.41% lifting the stock to HK$17.55. This comes even though the 1 year total shareholder return is a...
SEHK:2096
SEHK:2096Pharmaceuticals

Assessing Simcere Pharmaceutical Group (SEHK:2096) Valuation After Strong 2025 Earnings Report

Simcere Pharmaceutical Group (SEHK:2096) has drawn fresh attention after reporting full year 2025 sales of CN¥7,731.41 million and net income of CN¥1,344.01 million, alongside a proposed final dividend of CN¥0.18 per share. See our latest analysis for Simcere Pharmaceutical Group. At a latest share price of HK$13.62, Simcere Pharmaceutical Group has seen a 16.91% 1 month share price return and an 80.98% 1 year total shareholder return. Recent earnings, dividend and leadership announcements...
SEHK:3808
SEHK:3808Machinery

A Look At Sinotruk (Hong Kong) (SEHK:3808) Valuation After Strong 2025 Results And Higher Final Dividend Proposal

Sinotruk (Hong Kong) (SEHK:3808) has drawn fresh attention after reporting full year 2025 results with higher sales and net income, along with a board proposal to lift the ordinary final dividend for shareholders. See our latest analysis for Sinotruk (Hong Kong). The share price has responded strongly, with a 30 day share price return of 14.48% and a 90 day gain of 51.71%. The 1 year total shareholder return of 137.59% points to building momentum around the healthier earnings and higher...
SEHK:6855
SEHK:6855Biotechs

Assessing Ascentage Pharma Group International’s Valuation After Recent Share Price Momentum

Recent share performance and business snapshot Ascentage Pharma Group International (SEHK:6855) has drawn investor attention after recent share price moves, with returns of about 13% over the past week and 15% over the past month. The Suzhou based clinical stage biotech focuses on therapies for cancers, chronic hepatitis B and age related diseases in Mainland China. It generated HK$574.12 million in revenue and reported a net loss of HK$1,242.77 million. See our latest analysis for Ascentage...
SEHK:6699
SEHK:6699Medical Equipment

Assessing Angelalign Technology’s Valuation After Strong Earnings And Special Dividend Announcement

Why Angelalign Technology’s latest earnings and dividends matter for investors Angelalign Technology (SEHK:6699) has drawn fresh attention after releasing full year 2025 earnings, alongside a proposed special dividend of HK$4.99 per share and affirming its regular annual payout. See our latest analysis for Angelalign Technology. Since these results and dividend announcements, the share price has gained momentum, with a 30 day share price return of 11.71%, a year to date share price return of...
SEHK:639
SEHK:639Metals and Mining

Undervalued Asian Small Caps With Insider Action For April 2026

As global markets navigate the complexities of Middle East tensions and energy market volatility, Asian small-cap stocks present intriguing opportunities amid a backdrop of mixed economic signals. With key indices showing resilience and geopolitical uncertainties influencing investor sentiment, identifying promising small-cap companies requires a focus on those with robust fundamentals and strategic insider actions that align with current market dynamics.
SEHK:1828
SEHK:1828Insurance

FWD Group Holdings (SEHK:1828) Valuation Check After Recent Share Price Volatility

FWD Group Holdings: recent performance snapshot FWD Group Holdings (SEHK:1828) has drawn investor attention after recent share price moves, with the stock showing mixed short term returns and a last close of HK$31.18 on the Hong Kong market. See our latest analysis for FWD Group Holdings. Recent trading has been choppy, with a 1 day share price return of 1.52% decline and a 7 day share price return of 2.63% gain, set against a 30 day share price return of 10.66% decline and a year to date...
SEHK:3988
SEHK:3988Banks

The Bull Case For Bank of China (SEHK:3988) Could Change Following Higher 2025 Dividend Proposal

Bank of China Limited reported its full-year 2025 results, with net interest income of CNY 440.71 billion and net income of CNY 243.02 billion, and the board recommended a 2025 final dividend of CNY 1.169 per 10 shares, subject to shareholder approval. The bank also confirmed Ms. Huang Xueling’s appointment as Executive Vice President in late March 2026, highlighting ongoing leadership renewal alongside a higher proposed cash return to shareholders. We’ll now examine how the higher proposed...